MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 1 filers reported holding MOMENTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $684,573,000 | +16.5% | 13,044,450 | -26.1% | 0.07% | +6.2% |
Q2 2020 | $587,423,000 | +22.8% | 17,656,245 | +0.4% | 0.06% | -1.5% |
Q1 2020 | $478,484,000 | +39.7% | 17,591,341 | +1.3% | 0.07% | +73.7% |
Q4 2019 | $342,464,000 | +78.5% | 17,357,503 | +17.2% | 0.04% | +65.2% |
Q3 2019 | $191,887,000 | +4.2% | 14,806,095 | +0.1% | 0.02% | +4.5% |
Q2 2019 | $184,157,000 | -14.2% | 14,791,691 | +0.1% | 0.02% | -15.4% |
Q1 2019 | $214,700,000 | +31.7% | 14,776,364 | +0.0% | 0.03% | +18.2% |
Q4 2018 | $163,069,000 | -47.2% | 14,770,728 | +25.7% | 0.02% | -37.1% |
Q3 2018 | $308,951,000 | +29.9% | 11,747,215 | +1.0% | 0.04% | +29.6% |
Q2 2018 | $237,912,000 | +13.7% | 11,633,835 | +1.0% | 0.03% | +8.0% |
Q1 2018 | $209,165,000 | +30.9% | 11,524,252 | +0.6% | 0.02% | +31.6% |
Q4 2017 | $159,777,000 | -24.4% | 11,453,559 | +0.2% | 0.02% | -26.9% |
Q3 2017 | $211,458,000 | +12.5% | 11,430,184 | +2.7% | 0.03% | +13.0% |
Q2 2017 | $188,015,000 | +30.7% | 11,125,193 | +3.3% | 0.02% | +27.8% |
Q1 2017 | $143,826,000 | -10.5% | 10,773,450 | +0.9% | 0.02% | -14.3% |
Q4 2016 | $160,730,000 | +29.6% | 10,679,748 | +0.6% | 0.02% | +23.5% |
Q3 2016 | $124,047,000 | +8.0% | 10,611,392 | -0.2% | 0.02% | +6.2% |
Q2 2016 | $114,835,000 | +19.9% | 10,632,879 | +2.6% | 0.02% | +23.1% |
Q1 2016 | $95,793,000 | -37.6% | 10,367,166 | +0.2% | 0.01% | -38.1% |
Q4 2015 | $153,521,000 | -9.3% | 10,345,089 | +0.3% | 0.02% | -12.5% |
Q3 2015 | $169,313,000 | -23.5% | 10,317,660 | +6.3% | 0.02% | -14.3% |
Q2 2015 | $221,403,000 | +122.7% | 9,706,419 | +48.4% | 0.03% | +115.4% |
Q1 2015 | $99,436,000 | +193.2% | 6,541,814 | +132.2% | 0.01% | +225.0% |
Q4 2014 | $33,914,000 | +2.6% | 2,816,814 | -3.4% | 0.00% | 0.0% |
Q3 2014 | $33,069,000 | -5.6% | 2,916,125 | +0.5% | 0.00% | -20.0% |
Q2 2014 | $35,036,000 | -2.7% | 2,900,314 | -6.2% | 0.01% | 0.0% |
Q1 2014 | $36,019,000 | -30.4% | 3,091,748 | +5.7% | 0.01% | -28.6% |
Q4 2013 | $51,728,000 | +22.1% | 2,925,814 | -0.6% | 0.01% | +16.7% |
Q3 2013 | $42,350,000 | -14.7% | 2,943,034 | -10.8% | 0.01% | -25.0% |
Q2 2013 | $49,665,000 | – | 3,297,780 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,790,400 | $55,055,000 | 4.79% |
Camber Capital Management LP | 3,250,000 | $64,123,000 | 3.26% |
Avidity Partners Management LP | 200,000 | $3,946,000 | 2.49% |
Asymmetry Capital Management, L.P. | 62,585 | $1,235,000 | 2.21% |
Palo Alto Investors LP | 1,685,372 | $33,252,000 | 1.83% |
Monashee Investment Management LLC | 90,223 | $1,780,000 | 1.66% |
Greencape Capital Pty Ltd | 217,078 | $4,283,000 | 1.65% |
Redmile Group, LLC | 3,237,700 | $63,880,000 | 1.53% |
Ghost Tree Capital, LLC | 400,000 | $7,892,000 | 1.50% |
Perceptive Advisors | 2,835,637 | $55,947,000 | 1.11% |